Global Ocular Hypertension Treatment Market Size 2024, Forecast To 2033
6 Mar, 2024
The ocular hypertension treatment market size has grown steadily in recent years. It will grow from $5.14 billion in 2023 to $5.34 billion in 2024 at a compound annual growth rate (CAGR) of 3.7%. The growth in the historic period can be attributed to increased aging population, high incidence of glaucoma, advancements in diagnostic tools, awareness and screenings, lifestyle changes and urbanization. The ocular hypertension treatment market size is expected to see steady growth in the next few years. It will grow to $6.1 billion in 2028 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to rising global healthcare expenditure, advancements in treatment modalities, increased emphasis on personalized medicine, integration of telehealth services, rising geriatric population. Major trends in the forecast period include patient-centric approaches, regulatory landscape impact, global market expansion, technological advancements in monitoring devices, integration of artificial intelligence (AI).
Global Ocular Hypertension Treatment Market Key Driver
The increasing prevalence of glaucoma disease is anticipated to propel the growth of the ocular hypertension treatment market in the foreseeable future. Glaucoma, characterized by progressive optic nerve damage, poses a significant risk of vision impairment and blindness. Ocular hypertension, often associated with glaucoma, is marked by elevated intraocular pressure, contributing to the disease's advancement. The rising incidence of glaucoma is poised to positively influence the ocular hypertension treatment market. For instance, according to BrightFocus Foundation Highlights in October 2022, approximately 80 million individuals worldwide were affected by glaucoma, a figure projected to surpass 111 million by 2040. Thus, the increasing prevalence of glaucoma disease serves as a key driver behind the growth of the ocular hypertension treatment market.
Get A Free Sample Of The Global Ocular Hypertension Treatment Market ReportGlobal Ocular Hypertension Treatment Market Segments
The ocular hypertension treatment market covered in this report is segmented –
1) By Type: Intraocular Hypertension, Glaucoma
2) By Route of Administration: Oral, Parenteral, Other Routes
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Other Distribution Channel
4) By End-Users: Hospitals, Specialty Clinics, Others End-Users
By Geography:The regions covered in the ocular hypertension treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain
North America was the largest region in the ocular hypertension treatment market in 2023. The regions covered in the ocular hypertension treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Ocular Hypertension Treatment Industry Players
Angelini SpA, Laboratorios Sophia, Neurim Pharmaceuticals Ltd., Nicox SA, Novartis AG, AbbVie Inc., Alcon, Ocular Therapeutix Inc., Sylentis S.A, Taejoon Pharma Co. Ltd., Bausch Health Companies Inc., Merck & Co. Inc., Pfizer Inc., Teva Pharmaceutical Industries Ltd., Laboratorios Salvat SA, Shionogi & Co. Ltd., Otsuka Holdings Co. Ltd., Mitsubishi Tanabe Pharma Corporation, Astellas Pharma Inc., Eisai Co. Ltd., Daiichi Sankyo Company Limited, Celgene Corporation, Boehringer Ingelheim International GmbH, Eurofins Discover X Corporation, Novus Biologicals LLC, SK Bioscience Co., Regeneron Pharmaceuticals Inc., F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Company Limited
Get The Full Global Ocular Hypertension Treatment Market Report
Ocular Hypertension Treatment Market Overview
Ocular hypertension treatment refers to the treatment methods used to control and reduce high pressure inside eye or increased intraocular pressure (IOP) in people who have been diagnosed with ocular hypertension. This treatment is frequently used for optic nerve protection, visual function maintenance, and overall eye health.
Ocular Hypertension Treatment Global Market Report 2023 provides data on the global ocular hypertension treatment market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The ocular hypertension treatment market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.